Home/Filings/4/0000805928-23-000062
4//SEC Filing

Freitag Gregory Gene 4

Accession 0000805928-23-000062

CIK 0000805928other

Filed

Jun 4, 8:00 PM ET

Accepted

Jun 5, 6:47 PM ET

Size

11.0 KB

Accession

0000805928-23-000062

Insider Transaction Report

Form 4
Period: 2023-06-01
Transactions
  • Sale

    Common Stock

    2023-06-01$8.65/sh12,500$108,125319,615 total
  • Exercise/Conversion

    Restricted Stock Units

    2023-06-016,4590 total
    Common Stock (6,459 underlying)
  • Sale

    Common Stock

    2023-06-01$8.74/sh29,480$257,655290,135 total
  • Exercise/Conversion

    Common Stock

    2023-06-01+6,459296,594 total
Footnotes (5)
  • [F1]The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $8.57 to $8.75 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  • [F2]The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $8.66 to $8.83 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  • [F3]This reflects the number of restricted stock units that vested on June 1, 2023.
  • [F4]Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.
  • [F5]Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2023, one year from the anniversary of the grant date.

Issuer

Axogen, Inc.

CIK 0000805928

Entity typeother

Related Parties

1
  • filerCIK 0001492710

Filing Metadata

Form type
4
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 6:47 PM ET
Size
11.0 KB